2015

2015 - Beiträge in Fachzeitschriften

Originalarbeiten (Zeitschrift)
(2015): The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosis. BMC Nephrol. 2015; 16(4):196-196
(2015): Effects of zeolite supplementation on parameters of intestinal barrier integrity, inflammation, redoxbiology and performance in aerobically trained subjects. J Int Soc Sports Nutr. 2015; 12(2):40-40
(2015): Biomechanical properties and microstructure of human ventricular myocardium. Acta Biomater. 2015; 24(11):172-192
(2015): Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot Study. PLoS One. 2015; 10(10):e0141399-e0141399
(2015): Effectiveness of porcine dermal collagen in giant hernia closure in patients with deleterious fascia constitution after orthotopic liver transplantation. Transpl Int. 2015; 28(2):156-161
(2015): The Effect of Mammalian Target of Rapamycin Versus Calcineurin Inhibitor-based Immunosuppression on Measured Versus Estimated Glomerular Filtration Rate After Orthotopic Liver Transplantation. Transplantation. 2015; 99(6):1250-1256

2015 - Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Abstracts (Zeitschrift)
(2015): Prognostic Relevance of Rejection Episodes Detected Within the First 3 Weeks After Kidney Transplantation AM J TRANSPLANT. 2015; 15:
(2015): Eukaryotic translation initiation factors are overexpressed in colorectal carcinoma compared to -normal colorectalmucosa: Impact on the RTK/PI3K/Akt-mTOR pathway and putative therapeutic targets VIRCHOWS ARCH. 2015; 467: S8-S8.
(2015): Modulation of eukaryotic translation initiation factor expression in colorectal carcinoma by cytostatic and targeted medication as demonstrated in xenograft models VIRCHOWS ARCH. 2015; 467: S166-S166.
(2015): RESULTS OF JOINT REPLACEMENT IN PATIENTS AFTER SOLID ORGAN TRANSPLANTATION COMPARED TO NON-TRANSPLANTED PATIENTS TRANSPL INT. 2015; 28: 18-18.-Austrotransplant 2015; OCT 21-24, 2015; Kitzbühel, AUSTRIA.
(2015): Indications for and experience with the use of the wearable cardioverter defibrillator in patients at high risk for sudden cardiac death: a single center experience WIEN KLIN WOCHENSCHR. 2015; 127: S5-S6.
(2015): CARDIAC VOLUME OVERLOAD AND PULMONARY HYPERTENSION AFTER LONG-TERM FOLLOW-UP IN TIPS PATIENTS J HEPATOL. 2015; 62: S228-S228.
(2015): SERUM BILE ACIDS IN CIRRHOSIS DEPEND ON AETIOLOGY. J HEPATOL. 2015; 62(S2):S344-S344.-50th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 22-26, 2015; Vienna, AUSTRIA.
(2015): Probiotic supplementation improves liver function but fails to restore neutrophil phagocytosis in stable cirrhosis. A randomized, double-blind, placebo-controlled study HEPATOLOGY. . 2015; 62: 1216A-1216A.-66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 13-17, 2015; San Francisco, CA.
(2015): CALCIFICATION SCORE EVALUATION IN NTX LISTED PATIENTS TRANSPL INT. 2015; 28: 15-15.
(2015): IMPLEMENTATION OF A TRANSPLANT - APP FOR LIVER TRANSPLANT PATIENTS TRANSPL INT. 2015; 28: 16-16.
(2015): RISK-ADJUSTED ANALYSIS OF RELEVANT OUTCOME DRIVERS FOR PATIENTS AFTER MORE THAN TWO KIDNEY TRANSPLANTS TRANSPL INT. 2015; 28: 559-559.
(2015): EVOLUTION OF CARDIOVASCULAR RISK FACTORS IN LONG-TERM LIVER-TRANSPLANT RECIPIENTS: RELEVANCE OF PROCAM SCORE AND SMOKING STATUS TRANSPL INT. 2015; 28: 45-45.
(2015): RELEVANCE OF SMOKING STATUS IN LIVER TRANSPLANT RECIPIENTS: RISK FACTOR FOR ANASTOMOTIC STRICTURE AND RE-TRANSPLANTATION TRANSPL INT. 2015; 28: 46-46.
(2015): EARLY EVEROLIMUS-BASED TACROLIMUS REDUCTION IN DE NOVO LIVER TRANSPLANT RECIPIENTS: DESIGN AND BASELINE DATA FROM HEPHAISTOS STUDY J HEPATOL. 2015; 62: S850-S850.
(2015): Design and Baseline Data from Hephaistos Study Evaluating Efficacy and Safety of Early Initiation of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients TRANSPLANTATION. 2015; 99: 214-215.
(2015): HEPHAISTOS STUDY: DESIGN AND BASELINE DATA FROM EARLY INITIATION OF EVEROLIMUS-BASED TACROLIMUS REDUCTION IN DE NOVO LIVER TRANSPLANT RECIPIENTS TRANSPL INT. 2015; 28: 316-316.
(2015): Immunosuppression with a mTOR-Inhibitor Might Be Associated With a Lower CMV-DNA Incidence in Bile After Orthotopic Liver Transplantation TRANSPLANTATION. 2015; 99: 151-151.
(2015): The Role of Cytokines in the Development of Biliary Strictures : An Analysis of Biliary Fluids of Patients After Orthotopic Liver Transplanatation TRANSPLANTATION. 2015; 99: 151-151.
(2015): SERUM LEVELS OF CHEMOKINES CCL4 AND CCL5 IN CIRRHOTIC PATIENTS INDICATE THE PRESENCE OF HEPATOCELLULAR CARCINOMA TRANSPL INT. 2015; 28: 412-412.
(2015): MAINTENANCE IMMUNOSUPPRESSION WITH EVEROLIMUS AFTER LIVER TRANSPLANTATION (LTX), IMPEMENTATION IN WEEK 4: 6 YEARS OBSERVATION TRANSPL INT. . 2015; 28: 525-525.
(2015): LONG TERM IMMUNOSUPPRESSION WITH EVEROLIMUS AFTER LIVER TRANSPLANTATION (LTX), IMPLEMENTATION IN THE 4TH WEEK AFTER LTX: OBSERVATION OVER 6 YEARS TRANSPL INT. 2015; 28: 15-16.
(2015): GLYCINE IS GRAFT PROTECTIVE AND PRESERVES KIDNEY FUNCTION AFTER LIVER TRANSPLANTATION: DATA OF THE HEGPOL-TRIAL [ISRCTN69350312] TRANSPL INT. 2015; 28: 36-36.
(2015): Glycine is graft protective and preserves kidney function after liver transplantation: Data of the HEGPOL-Trial [ISRCTN69350312] HEPATOLOGY. 2015; 62: 817A-817A.
(2015): A 10 Min &quotNo-Touch&quot Time Is It Enough in DCD? A DCD Animal Study AM J TRANSPLANT. 2015; 15: -American Transplant Congress; MAY 02-06, 2015; Philadelphia, PA.
(2015): INTERFERON-FREE ANTI-HCV THERAPY AFTER ORGAN TRANSPLANTATION TRANSPL INT. 2015; 28: 11-11.
(2015): Everolimus and Early Calcineurin Inhibitor Withdrawal Is Associated With Superior Renal Function: 5-Year Follow-Up of the Randomized PROTECT Liver Transplantation Study AM J TRANSPLANT. 2015; 15:
(2015): 5-YEAR FOLLOW-UP RESULTS OF THE PROTECT LIVER TRANSPLANTATION STUDY: EVEROLIMUS AND EARLY CALCINEURIN INHIBITOR WITHDRAWAL IS ASSOCIATED WITH SUPERIOR RENAL FUNCTION TRANSPL INT. 2015; 28: 31-31.
(2015): 5-YEAR FOLLOW-UP OF THE PROTECT RANDOMISED LIVER TRANSPLANTATION STUDY SHOWED SUPERIOR RENAL FUNCTION WITH EVEROLIMUS AND EARLY CALCINEURIN INHIBITOR WITHDRAWAL TRANSPL INT. 2015; 28: 90-90.
(2015): A MULTIDRUG STRATEGY TO ATTENUATE ISCHEMIA REPERFUSION INJURY IN EXPERIMENTAL LIVER TRANSPLANTATION J HEPATOL. 2015; 62: S293-S294.